Picture courtesy: India TV
Hyderabad: COVID-19 vaccine, Covaxin will be effective in treating the new strain that has created a panic worldwide, Bharat Biotech said on Tuesday.
According to Bharat Biotech Chairman and Managing Director Krishna Ella, the protein components of inactive Covaxin can take care of mutations, reported news agency IANS.
Ella’s comments came amid increasing concerns over new strains of coronavirus SARS-CoV-2, especially the variant that was detected recently in the United Kingdom.
Ella, who was delivering the Telangana Academy of Sciences-organised ninth Dr Manohar VN Shirodkar Memorial Lecture, observed that any virus is likely to have a lot of mutation.
Covaxin is being developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
ALSO READ: Oxford Vaccine Will Protect 95 Per Cent: AstraZeneca CEO
Mumbai: Abhishek Bachchan’s highly-anticipated film ‘I Want To Talk’ released in theatres on Friday, and the…
New Delhi: Accused of giving cash to secure votes ahead of election day in Maharashtra,…
Bhubaneswar: Chief Minister Mohan Charan Majhi attended the ‘Odisha State Day Celebrations’ at the 43rd…
Mumbai: Recently, some morphed pictures of actress Shweta Tiwari and her good friend Vishal Aditya…
Phulbani: Two tribal men were sentenced to life imprisonment by a special court in Odisha's…
New Delhi: It’s been just over two months since Atishi took oath as Delhi’s chief…
Bhubaneswar: In a moment of pride for AIIMS Bhubaneswar, Dr Manita Tamang, a final-year Senior…
Imphal: In view of the surge in violence in troubled Manipur, the Central government will send…